This metabolite incorporates a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 around fifty% of the mum or dad drug. Plasma concentrations of this metabolite are around forty% of These witnessed for sildenafil, so which the metabolite accounts for about 20% of sildenafil's pharmacologic outcomes.This document won't